Interferon-β Treatment for Multiple Sclerosis
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Neurotherapeutics
- Vol. 4 (4) , 633-646
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Treatment of pediatric multiple sclerosis and variantsNeurology, 2007
- Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaMultiple Sclerosis Journal, 2007
- Italian studies on early-onset multiple sclerosis: the present and the futureNeurological Sciences, 2004
- Impact of Disease‐Modifying Therapies on Brain and Spinal Cord Atrophy in Multiple SclerosisJournal of Neuroimaging, 2004
- Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Cost-utility of interferon β 1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosisThe European Journal of Health Economics, 2003
- Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsMultiple Sclerosis Journal, 2000
- Managing the Adverse Effects of Interferon-?? Therapy in Multiple SclerosisDrug Safety, 2000
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993